Registration

BGR GOVERNMENT AFFAIRS for BAYER CORPORATION

Firm
Client
Income
—
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Provide lobbying support on key issues, provide intelligence and policy tracking of federal policy developments.

LobbyistCovered position, as disclosed
DAVID BOYER New Sp Ast Pres LA, Ast Com Leg, FDA; Sp Ast Sec HHS, Con Asst; Off of WH Liaison DoD; Con Asst, Off of Sec Lab
BRENT ALAN DEL MONTE New Leg. Dir. Rep. Bliley; Sen. Counsel House Energy & Commerce Committee
MATT HOFFMANN New St. Asst. Rep. Vitter; LC Rep. Vitter; Sen. LC .Rep. Vitter; LA Rep. Paul Ryan; Sen. LA Rep. Paul Ryan; LD Rep. Paul Ryan; Budget Analyst Rep. Paul Ryan; St. Dir. Health Subcmte House W&M Cmte; Policy Analyst Off. Speaker; Policy Dir. Sen. Fin Cmte.
REMY LEIGH BRIM MASON New Senior FDA Policy Advisor to the Senate HELP Committee Ranking Member, Sen. Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren
JOHN STONE New Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Ctme Health Subcommittee
ROBB WALTON New Senior Health Policy Advisor and Counsel Sen Cassidy; Advisor Rep. Cassidy; Healthcare Aide Sen. Enzi

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
BAYER AG Germany Germany 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.